On these bases, we designed the present study to explore the impact of BS on SHBG, as well as the potential role of SHBG as reliable biomarker for predicting TWL and WR after BS in patients with obesity. The gene discussed is SHBG; the disease is obesity due to melanocortin 4 receptor deficiency.